Jump to main content
Jump to site search

Issue 69, 2018
Previous Article Next Article

Branch-PCR constructed TP53 gene nanovector for potential cancer therapy

Author affiliations

Abstract

A novel and efficient branch PCR strategy has been used to construct a TP53 gene nanovector based on a pair of trimers as primers, which showed unique advantages compared to other existing systems for gene delivery and effective potential cancer therapy.

Graphical abstract: Branch-PCR constructed TP53 gene nanovector for potential cancer therapy

Back to tab navigation

Supplementary files

Publication details

The article was received on 26 Jun 2018, accepted on 31 Jul 2018 and first published on 01 Aug 2018


Article type: Communication
DOI: 10.1039/C8CC05066J
Citation: Chem. Commun., 2018,54, 9687-9690
  •   Request permissions

    Branch-PCR constructed TP53 gene nanovector for potential cancer therapy

    L. Cheng, H. Deng, D. Ma, B. Zhai, Q. Zhang, L. Li and Z. Xi, Chem. Commun., 2018, 54, 9687
    DOI: 10.1039/C8CC05066J

Search articles by author

Spotlight

Advertisements